1Department of Medical Oncology, Royal Prince Alfred Hospital, Sydney, NSW.
Establishing ambulatory chemotherapy programs for home-based 5-fluorouracil (5-FU) infusions is feasible. Patient preference significantly influences device selection, with Portacath emerging as a preferred venous access device (VAD).
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: